Skip to main content
logo
Onyx Biotec Limited (NSE:ONYX)
India flag India · Delayed Price · Currency is INR
38.90
+1.85 (4.99%)
At close: Jul 27, 2026

Onyx Biotec Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
694.69694.69619.51537.49394.92448.61
Revenue Growth
4.64%12.13%15.26%36.10%-11.97%-
Gross Profit
178.17178.17218.55170.21173.59169.51
Operating Income
3.453.4573.2365.0130.5442.79
Net Income
-2.14-2.1449.5436.3518.4533.53
Earnings Per Share
-0.12-0.123.313.051.562.84
EPS Growth
--8.60%95.20%-45.07%-

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
40.3740.3786.1214.670.070.14
Total Debt
151.71151.71124.58307.8292.28122.44
Net Cash (Debt)
-111.34-111.34-38.46-293.14-292.21-122.3
Net Cash Growth
------
Net Cash Per Share
-6.23-6.23-2.57-24.56-24.76-10.36

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-14.94-14.9414.1715.1662.364.85
Capital Expenditures
-49.87-49.87-10.55-32.23-227.37-57.86
Free Cash Flow
-64.81-64.813.62-17.07-165.01-53
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
25.65%25.65%35.28%31.67%43.95%37.79%
Operating Margin
0.50%0.50%11.82%12.09%7.73%9.54%
Pretax Margin
-0.61%-0.61%10.46%8.35%6.45%8.46%
Profit Margin
-0.31%-0.31%8.00%6.76%4.67%7.47%
FCF Margin
-9.33%-9.33%0.58%-3.17%-41.78%-11.82%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJul '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
--21.23---
P/FCF Ratio
--290.43---
PS Ratio
1.060.891.70---